BGI Australia
Founded in Brisbane in 2016
- BGI Australia, a subsidiary of the BGI Group, was established in April 2016 to support its growth in the Oceania. Its facility is located on level 6 in the prestigious QIMR Berghofer Medical Research Institute in Brisbane, Queensland.
- Affiliated to one of the world's largest genomics organisations, BGI Australia is supercharged with the BGI Group's unique technological advantage of the proprietary genome sequencing platform DNBSEQ™ and best-in-class bioinformatic analysis capabilities.
- Dedicated to facilitating cutting-edge research in healthcare, agriculture, environment and other related areas, BGI Australia is continuously seeking collaborative opportunities in the region to pursue scientific excellence by incorporating existing resources to contribute to the vision of using genomics to benefit the whole mankind.
BGI Australia Laboratory
- BGI Australia Laboratory, the BGI Group’s first southern hemisphere genome sequencing laboratory, was launched in May 2017, unveiling of its cutting-edge sequencer's debut in this part of the world. Being a subsidiary of the world's largest genomic organisation with leading gene sequencing platform and superb genome sequencing and bioinformatics analysis capability, BGI Australia is devoted to facilitating cutting-edge research in the areas of healthcare, agriculture and environment.
Local Research Collaborations
- Since its inception BGI Australia's strategic research hub in Brisbane acts as the headquarters for its business development in the Australia and New Zealand region, and has incessantly been strengthening ties to the science community across the country by forming extensive genomics research collaborations with Australian medical research institutes, universities, and industry partners, including Queensland Institute of Medical Research (QIMR), the University of Queensland, Griffith University, James Cook University, the University of Melbourne, Olivia Newton-John Cancer Research Institute and more, in a wide range of areas including medicine and health, marine biology, agriculture and aquaculture.
Strategic Focus
- Collaborating with Australia's scientific organisations to advance research and discoveries in genomics, medical health, agriculture and biodiversity.
- Establishing a centralised platform to provide genome sequencing technology transfer, training, services and industry incubation to the community.
- Providing proprietary DNBSEQ sequencing systems, analysis tools and services to healthcare providers to promote Australian’s public well-being in areas of reproductive health, cancer, rare diseases, and infectious diseases.
- Developing agriculture and aquaculture with advanced molecular breeding technology and agrigenomics-related research.